Oxford Ledge
Search
No licensed closing price on file for TECX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 11:28 UTC.
Tectonic Therapeutic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-protein coupled receptors, or GPCRs, which are receptor molecules on cell surfaces that regulate diverse biological functions including blood pressure and glucose metabolism. The company has created a proprietary technology platform called GEODe to address the historical difficulty of discovering biologics that can modulate GPCRs, as these molecules are challenging to work with due to their low expression levels and instability outside cells.
Summarized from Tectonic Therapeutic, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
Charts, 10-year financials, peer comparison, screening and portfolio tracking for TECX and 5,000+ tickers.
Create a free account — keep TECXGET /api/data?ticker=TECX
This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt